3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Sarcoma
12
Lymphoma, Large B-Cell, Diffuse
12
Sarcoma, Ewing
4
Lymphoma, B-Cell
4
Recurrence
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Osteosarcoma
3
Neurofibrosarcoma
3
Lymphoma, Non-Hodgkin
3
Liposarcoma
3
Hodgkin Disease
3
Fibrosarcoma
3
Sarcoma, Synovial
2
Sarcoma, Clear Cell
2
Rhabdomyosarcoma
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Neuroblastoma
2
Nerve Sheath Neoplasms
2
Neoplasms, Germ Cell and Embryonal
2
Lymphoma, Follicular
2
Lymphoma
2
Leiomyosarcoma
2
Histiocytoma, Malignant Fibrous
2
Histiocytoma, Angiomatoid Fibrous
2
Hemangiosarcoma
2
Granuloma, Plasma Cell
2
Desmoplastic Small Round Cell Tumor
2
Dermatofibrosarcoma
2
Chondrosarcoma, Extraskeletal Myxoid
2
Burkitt Lymphoma
2
Interventions
fludarabine
19
Whole-Body Irradiation
18
Cyclophosphamide
17
fludarabine phosphate
16
ruxolitinib
15
Mycophenolic Acid
14
Specimen Handling
13
Tacrolimus
11
Azacitidine
11
Biopsy
10
Peripheral Blood Stem Cell Transplantation
9
Melphalan
9
Cytarabine
9
venetoclax
8
Sirolimus
8
Busulfan
8
Stem Cell Transplantation
6
Injections
6
Granulocyte Colony-Stimulating Factor
6
Daunorubicin
5
Cyclosporine
5
CPX-351
5
luspatercept
4
ivosidenib
4
itacitinib
4
fedratinib
4
decitabine and cedazuridine drug combination
4
Thiotepa
4
Liposomes
4
Cyclosporins
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Myeloproliferative Disorders
×
Ifosfamide
×
1 year
×
Clear all
No trials found.